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Nonalcoholic steatohepatitis (NASH) is emerging as themost
prevalent liver disease in industrialized countries. NASH
is associated with increased liver-related mortality due to
cirrhotic and tumorigenic evolution and it is estimated that
it will become the leading cause for liver transplantation in
the next few years. Apart from liver morbidity, patients with
NASH are also at increased risk for cardiovascular mortality,
because these patients display endothelial dysfunction and
a prothrombotic tendency. Thus, one hot topic in the field
of NASH research is the identification of molecular factors
involved in the progression of liver damage and cardio-
vascular dysfunction. One further challenge is to develop
tools for the noninvasive diagnosis of NASH and for the
assessment of fibrosis; although several efforts have been
made, there is still a need to findmore accurate and affordable
tests. Finally, the main challenge for the clinician involved
in the management of patients with NASH is treatment.
Few patients are compliant with lifestyle modifications and
pharmacological treatments, proposed so far, have been
reported to have limited efficacy and safety.
This special issue on NASH reports original articles
from basic and clinical researchers that give interesting
contributions to the understanding of the pathogenesis and
the clinical management of NASH. The issue contains also
review articles from leading scientists that provide state-of-
the-art view on specific topics. We hope that these articles
may be of some inspiration to investigators and may help
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